Search

Author/Creator Lin, Chester

1. A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers. (6th March 2018)

Authors:
Tolcher, Anthony; Flaherty, Keith; Shapiro, Geoffrey I.; Berlin, Jordan; Witzig, Thomas; Habermann, Thomas; Bullock, Andrea; Rock, Edwin; Elekes, Agnes; Lin, Chester; Kostic, Dusan; Ohi, Naoto; Rasco, Drew; Papadopoulos, Kyriakos P.; Patnaik, Amita; Smith, Lon; Cote, Gregory M.
Journal:
Oncologist
Issue:
Volume 23:Number 6(2018)
Page Start:
658
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 1, open-label, randomized drug–drug interaction study of zanubrutinib with moderate or strong CYP3A inhibitors in patients with B-cell malignancies. Issue 2 (28th January 2023)

Authors:
Tariq, Bilal; Ou, Ying C.; Stern, Jennifer C.; Mundra, Vaibhav; Wong Doo, Nicole; Walker, Patricia; Lewis, Katharine L.; Lin, Chester; Novotny, William; Sahasranaman, Srikumar; Opat, Stephen
Journal:
Leukemia & lymphoma
Issue:
Volume 64:Issue 2(2023)
Page Start:
329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search